Berger Franklin M's Form 4 filing
ESSA Pharma Inc. (EPIX) · filed Jan 5, 2023
- Accession no.
- 0000899243-23-000914
- Filed
- Jan 5, 2023
- Trade date
- Dec 14-21, 2022
- Filing delay
- 22 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $729.1K. It was filed 22 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Berger Franklin MCIK 0001273885 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | Common Shares | SSaleDisposed | −25,000 | $3.00 | −$75,000 | 932,244 | Direct | |
| Dec 15, 2022 | Common Shares | SSaleDisposed | −32,000 | $2.90 | −$92,800 | 900,244 | Direct | |
| Dec 15, 2022 | Common Shares | SSaleDisposed | −50,000 | $2.86 | −$143,000 | 850,244 | Direct | |
| Dec 16, 2022 | Common Shares | SSaleDisposed | −50,000 | $2.67 | −$133,500 | 800,244 | Direct | |
| Dec 20, 2022 | Common Shares | SSaleDisposed | −43,617 | $2.53 | −$110,351.01 | 756,627 | Direct | |
| Dec 21, 2022 | Common Shares | SSaleDisposed | −37,889 | $2.41 | −$91,312.49 | 718,738 | Direct | |
| Dec 21, 2022 | Common Shares | SSaleDisposed | −34,334 | $2.42 | −$83,088.28 | 684,404 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.